Cite
HARVARD Citation
Dubé, M. et al. (2019). A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clinical infectious diseases. pp. 1165-1172. [Online].